InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（7 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
7
T+90 胜率
0%
T+90 平均收益
0.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Blickenstaff Kim d. Director active across 3 companies, notably TANDEM DIABETES CARE INC. In total, 14 filings have been logged. Split: 1 buy · 7 sells. Total volume traded: €8.7m. Activity tracked since 27 May 2021. The latest transaction was disclosed on 20 November 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Blickenstaff Kim d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
10,000 股@ US$30.003.0% 占其流量Common StockSEC:0001438133-24-000217:0
172,189 股@ US$2.9043100.0% 占其流量Class A Common StockSEC:0001415889-24-016680:0
标准退出：2024年9月9日 (T+90)
4,434 股@ US$51.732.3% 占其流量Common StockSEC:0001438133-24-000119:0
2,757 股0Common StockSEC:0001438133-23-000111:0
6,560 股@ US$9.000.0037% mcap0.6% 占其流量Common StockSEC:0001438133-22-000087:0
28,400 股@ US$113.3528.9% 占其流量Common StockSEC:0001438133-21-000157:0
28,700 股@ US$3.500.9% 占其流量Common StockSEC:0001438133-21-000155:0
24,240 股@ US$109.069823.9% 占其流量Common StockSEC:0001438133-21-000135:0
13,990 股@ US$105.499213.4% 占其流量Common StockSEC:0001438133-21-000133:0
3,210 股@ US$107.20693.1% 占其流量Common StockSEC:0001438133-21-000129:0
2,800 股@ US$109.39392.8% 占其流量Common StockSEC:0001438133-21-000125:0
10,000 股@ US$91.518.0% 占其流量Common StockSEC:0001438133-21-000102:0
17,123 股@ US$87.4113.1% 占其流量Common StockSEC:0001438133-21-000096:0
1,892 股0Common StockSEC:0001438133-21-000081:0
14 条申报中的 14 条
About Blickenstaff Kim d
Blickenstaff Kim D is a declarant and has 14 filings in total. Across the sampled recent filings from 2021-06-01 to 2024-11-22, the buy amount is EUR 465617 and the sell amount is EUR 8277181, with the modal transaction nature listed as Cession. He is a Director at Tandem Diabetes Care INC and a Director at Nuvation Bio Inc.
